Clinical Trials Directory

Trials / Conditions / Unresectable Gallbladder Carcinoma

Unresectable Gallbladder Carcinoma

8 registered clinical trials studyying Unresectable Gallbladder Carcinoma.

StatusTrialSponsorPhase
Active Not RecruitingStudy of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A Co
NCT05564403
National Cancer Institute (NCI)Phase 2
CompletedGemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnos
NCT03768414
SWOG Cancer Research NetworkPhase 3
Active Not RecruitingGuadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder C
NCT03257761
University of Southern CaliforniaPhase 1
CompletedRamucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot B
NCT02520141
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingRecombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or
NCT02495896
University of Southern CaliforniaPhase 1
CompletedGemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Bili
NCT02392637
M.D. Anderson Cancer CenterPhase 2
CompletedMK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery
NCT01425879
National Cancer Institute (NCI)Phase 2
CompletedSorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Me
NCT01093222
National Cancer Institute (NCI)Phase 2